1. Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis
- Author
-
Ngamkae Ruangvaravate, Nacha Chanvarapha, Patthanee Samsen, Niphon Chirapapaisan, Atiporn Thuangtong, Sawarin Laotaweerungsawat, and Wanicha Chuenkongkaew
- Subjects
Adult ,Male ,medicine.medical_specialty ,Multiple Sclerosis ,genetic structures ,Adolescent ,Audiology ,Young Adult ,Predictive Value of Tests ,Physiology (medical) ,medicine ,Humans ,Optic neuritis ,Latency (engineering) ,Young adult ,False Negative Reactions ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Multiple sclerosis ,Reproducibility of Results ,Retrospective cohort study ,Magnetic resonance imaging ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Sensory Systems ,Ophthalmology ,P100 Latency ,Predictive value of tests ,Evoked Potentials, Visual ,Female ,business - Abstract
Prolonged latency of visual evoked potentials (VEP) has been used to identify clinically silent lesions in multiple sclerosis (MS) suspects. The objective of this study was to determine the reliability of VEP to predict the development of MS in MS suspects. Retrospective hospital records of MS suspects were evaluated. VEP was analyzed together with subsequent diagnostic confirmation of MS by McDonald diagnostic criteria for MS-2005. MS developed in 12 of 35 patients (34 %) and 23 (66 %) failed to exhibit diagnostic characteristics. P100 latencies and interocular latency differences were longer in clinically definite multiple sclerosis (CDMS) than non-CDMS patients (p = 0.002, 0.001, respectively). All patients in the subsequent MS group had P100 latencies longer than102 ms, a mean of our MS-free subjects thus providing 100 % of sensitivity. No patient developed MS with a P100 latency
- Published
- 2014